Progesterone-like relaxant effect of RU 486 in the rat myometrium

Area of Science:

• Reproductive Endocrinology
• Pharmacology
• Cell Physiology

Background:

• RU 486 (mifepristone) is a known antiprogesterone and antiglucocorticoid.
• Genomic effects of RU 486 involve nuclear receptor binding.
• Non-genomic effects, occurring rapidly outside the nucleus, are less understood.

Purpose of the Study:

• To investigate the potential non-genomic effects of RU 486.
• To compare RU 486's rapid effects on uterine contractility with progesterone and pregnanolone.
• To determine if RU 486 influences calcium-mediated cellular processes.

Main Methods:

• In vitro assessment of rat uterine contractility.
• Comparison of RU 486, progesterone, and 5 beta-progestin pregnanolone effects.
• Evaluation of RU 486's antagonism of calcium-induced contractions.

Main Results:

• RU 486 exhibited a significant relaxant effect on uterine smooth muscle.
• This relaxant effect was comparable to progesterone but less potent than pregnanolone.
• RU 486 effectively antagonized contractions induced by calcium, similar to endogenous steroids.

Conclusions:

• RU 486 elicits rapid non-genomic effects on uterine contractility.
• The data suggest RU 486 may act by blocking calcium channels.
• These non-genomic actions occur prior to the compound's genomic effects within the cell.